TVRD Tingkat bathi reged Cara Therapeutics, Inc.

Lambang korporat lan logo Cara Therapeutics, Inc. (TVRD)

Cara Therapeutics Inc develops innovative selective agonists to combat renal pruritus. Competent management effectively engages with regulators, achieving its established goals. The gross profit margin helps assess the real value of the business, while 0.00 reflects the latest level of this metric. However, a reduction in research staff and the abandonment of several programs have limited internal development.

Tingkat bathi miturut bathi reged caratherapeutics.com (TVRD): kanggo periode 04.07.2022 - 20.11.2026

Rincian metrik keuangan lan pasar Cara Therapeutics Inc (TVRD)

- nilai pasar lan prakiraan target analis:
- rincian posisi dhuwit lan arus kas:
Pambiji fundamental:TVRD Cara Therapeutics, Inc.
Barang unggulan Cara Corp

Gross margin determines production efficiency by measuring the portion of revenue remaining after direct product creation costs. Analyzing the gross profit margin allows for an assessment of the financial stability of Cara Therapeutics Inc (TVRD), where patent protection and the chronic nature of kidney diseases ensure a stable cash flow and high profitability for each unit of the drug sold.